KR890001540A - 심부전증 치료제 - Google Patents

심부전증 치료제 Download PDF

Info

Publication number
KR890001540A
KR890001540A KR1019880007872A KR880007872A KR890001540A KR 890001540 A KR890001540 A KR 890001540A KR 1019880007872 A KR1019880007872 A KR 1019880007872A KR 880007872 A KR880007872 A KR 880007872A KR 890001540 A KR890001540 A KR 890001540A
Authority
KR
South Korea
Prior art keywords
heart failure
failure treatment
group
integer
treatment
Prior art date
Application number
KR1019880007872A
Other languages
English (en)
Other versions
KR960007752B1 (ko
Inventor
기요시 이리에
사또시 꾸니따다
시니찌로 아시다
Original Assignee
스즈끼 다다시
다이찌 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스즈끼 다다시, 다이찌 세이야꾸 가부시끼가이샤 filed Critical 스즈끼 다다시
Publication of KR890001540A publication Critical patent/KR890001540A/ko
Application granted granted Critical
Publication of KR960007752B1 publication Critical patent/KR960007752B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatment Of Sludge (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • External Artificial Organs (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음

Description

심부전증 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 활성 성분으로서 일반식(I)의 화합물 또는 이의 약제학적으로 허용되는 염을 함유함을 특징으로 하는, 심부전증 예방 및 치료제.
    상기 식에서 R은 이미다졸릴 그룹, 티아졸릴 그룹 또는 피리딜 그룹을 나타내고 ; n은 1 또는 2를 나타내며 ; m은 1 내지 4의 정수를 나타낸다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임
KR1019880007872A 1987-07-01 1988-06-29 심부전증 치료제 KR960007752B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP16438787 1987-07-01
JP164387/87 1987-07-01
JP62-164387 1987-07-01

Publications (2)

Publication Number Publication Date
KR890001540A true KR890001540A (ko) 1989-03-27
KR960007752B1 KR960007752B1 (ko) 1996-06-12

Family

ID=15792156

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880007872A KR960007752B1 (ko) 1987-07-01 1988-06-29 심부전증 치료제

Country Status (12)

Country Link
US (1) US4933349A (ko)
EP (1) EP0297593B1 (ko)
JP (1) JPH01104013A (ko)
KR (1) KR960007752B1 (ko)
AT (1) ATE88634T1 (ko)
AU (1) AU609834B2 (ko)
CA (1) CA1309028C (ko)
DE (1) DE3880564T2 (ko)
DK (1) DK360388A (ko)
IL (1) IL86846A (ko)
PH (1) PH24636A (ko)
ZA (1) ZA884697B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them
US5354770A (en) * 1989-02-27 1994-10-11 Daiichi Pharmaceutical Co., Ltd. Using imidazolyl tetrahydronaphthalene carboxylic acids to inhibit restenosis
ZA901416B (en) * 1989-02-27 1990-12-28 Daiichi Seiyaku Co Post-ptca restenosis inhibitor
WO1991015207A1 (fr) * 1990-04-09 1991-10-17 Daiichi Pharmaceutical Co., Ltd. Medicament pour syndromes respiratoires obstructifs
WO2002039002A1 (en) * 2000-11-07 2002-05-16 Lozon Llc Splicing device and method for sealing conduit spaces
US10130267B2 (en) * 2012-03-08 2018-11-20 Medtronic, Inc. Heart sound monitoring of pulmonary hypertension

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative

Also Published As

Publication number Publication date
CA1309028C (en) 1992-10-20
DE3880564T2 (de) 1993-08-12
DK360388D0 (da) 1988-06-30
US4933349A (en) 1990-06-12
AU609834B2 (en) 1991-05-09
DK360388A (da) 1989-01-02
EP0297593A2 (en) 1989-01-04
JPH0552813B2 (ko) 1993-08-06
EP0297593A3 (en) 1990-08-01
KR960007752B1 (ko) 1996-06-12
IL86846A (en) 1992-03-29
PH24636A (en) 1990-08-17
DE3880564D1 (de) 1993-06-03
ATE88634T1 (de) 1993-05-15
JPH01104013A (ja) 1989-04-21
ZA884697B (en) 1989-03-29
EP0297593B1 (en) 1993-04-28
AU1855088A (en) 1989-01-05

Similar Documents

Publication Publication Date Title
KR870005637A (ko) 약물 데포
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
KR950016732A (ko) 피부 및 질의 위축 억제방법
KR950016726A (ko) 기능부전성 자궁 출혈을 억제하는 방법
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
KR927003525A (ko) 술폰아닐리드 유도체 및 의약
KR910004191A (ko) 신질환치료제
KR950016747A (ko) 여성의 임신 억제방법
KR950016760A (ko) 치질 치료제
KR950016735A (ko) 터너 증후군의 억제 방법
KR890001540A (ko) 심부전증 치료제
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
KR970061248A (ko) 알츠하이머병 치료용 1, 1, 2-트리페닐부트-1-엔 유도체
KR920703050A (ko) 골형성 촉진제
KR900701262A (ko) 췌장염 등에 대한 치료제
KR890001543A (ko) 당뇨병 치료제
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
KR980002033A (ko) 트리아졸 유도체 또는 그 염
KR910000148A (ko) 말초순환 장애용 치료제
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물
KR890014101A (ko) 동맥경화증 치료제
KR900017599A (ko) 종양 치료용 약학 조성물
KR890016027A (ko) 벤즈티아졸 살진균제
KR890017363A (ko) 스트로빌루린 유도체, 이들의 제법 및 용도

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee